NEW YORK, December 21, 2016 /PRNewswire/ --
Specialty chemicals, or effect chemicals, provide different effects when added to different chemical or substances. They are used under diverse categories such as adhesives, agrichemicals, cleaning materials, cosmetic additives, and construction chemicals, among many others. In today's pre-market research, Stock-Callers.com shifts focus on the following stocks: Chemtura Corp. (NYSE: CHMT), The Sherwin-Williams Co. (NYSE: SHW), Methanex Corp. (NASDAQ: MEOH), and Senomyx Inc. (NASDAQ: SNMX). Learn more about these stocks by downloading their free report at:
At the close on Tuesday, shares in Pennsylvania-based Chemtura Corp. ended the day flat at $33.15. The stock recorded a trading volume of 662,663 shares. The Company's shares have advanced 21.30% in the previous three months and 21.56% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 0.54% and 13.73%, respectively. Moreover, shares of Chemtura, which together with its subsidiaries, develops, manufactures, and markets performance-driven engineered industrial specialty chemicals for industrial manufacturing customers in the US and internationally, have a Relative Strength Index (RSI) of 53.43.
On October 31st, 2016, Chemtura reported Q3 2016 GAAP earnings from continuing operations of $0.39 per diluted share compared to $0.45 per diluted share for Q3 2015. For the reported quarter, the Company generated net sales of $414 million, down 7% compared to net sale of $444 million in Q3 2015. The free research report on CHMT is available at:
Shares in Ohio headquartered The Sherwin-Williams Co. ended the day 1.00% lower at $266.19 with a total trading volume of 806,231 shares. In the last month and since the start of this year, the stock has gained 2.27% and 3.79%, respectively. The Company's shares are trading above their 50-day moving average by 1.15%. Furthermore, shares of Sherwin-Williams, which develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America, the Caribbean, Europe, and Asia, have an RSI of 45.22.
On November 29th, 2016, research firm Atlantic Equities initiated an 'Overweight' rating on the Company's stock.
On December 19th, 2016, Sherwin-Williams and The Valspar Corp. issued a statement in response to unfounded market rumors concerning regulatory approvals for the definitive agreement between Sherwin-Williams and Valspar, announced on March 20th, 2016. Sherwin-Williams and Valspar stated that they continue to cooperate fully with the FTC staff and continue to expect the transaction will close by the end of Q1 2017. Given the complementary nature of the businesses and the benefits this transaction will provide to customers, the companies believe that no or minimal divestitures should be required to complete the transaction. The complimentary report on SHW can be downloaded at:
On Tuesday, shares in Canada headquartered Methanex Corp. finished 0.33% lower at $45.30 with a total trading volume of 518,487 shares. The stock has advanced 20.09% in the last one month, 50.61% over the previous three months, and 41.67% on an YTD basis. The Company's shares are trading above their 50-day and 200-day moving averages by 14.82% and 37.88%, respectively. Additionally, shares of Methanex, which produces and supplies methanol in the Asia Pacific, North America, Europe, and South America, have an RSI of 65.98.
On October 26th, 2016, Methanex reported a net loss attributed to its shareholders of $11 million, or $0.12 net loss per common share on a diluted basis, for Q3 2016 compared to a net loss of $3 million, or $0.08 net loss per common share on a diluted basis, in Q2 2016. The Company stated that it achieved another Company record in Q3 2016 with a 5% increase in sales to 2,476,000 tonnes. Sales of produced methanol were also a quarterly record of 1,860,000 tonnes.
On November 30th, 2016, research firm Cowen reiterated its 'Outperform' rating on the Company's stock with an increase of the target price from $40 to $48. Visit us today and download our complete research report on MEOH for free at:
California headquartered Senomyx Inc.'s shares recorded a trading volume of 422,828 shares, and closed the day 2.83% lower at $0.86. The stock is trading below its 50-day moving average by 44.53%. Shares of the Company, which discovers, develops, and commercializes flavor ingredients for the packaged food, beverage, and ingredient supply industries using proprietary taste receptor-based assays and screening technologies, have an RSI of 26.31.
On October 27th, 2016, Senomyx reported that total revenues for Q3 2016 were $6.0 million. The Company's Commercial revenues were $2.5 million in Q3 2016 compared to $3.0 million for Q3 2015. Research, development, and patent expenses decreased to $5.24 million in Q3 2016 from $6.16 million in Q3 2015. Senomyx's net loss for Q3 2016 widened to $2.46 million compared to $2.41 million in Q3 2015. Get free access to your technical report on SNMX at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA